Skip to content
Screener

Bio-Rad Laboratories BIO All Other Segments — Net Sales

Other segment segments

Clinical Diagnostics
$363.6M+1.9%
Life Science
$228.5M0.0%

Similar metrics at other companies

The J.M. Smucker Company logo
SJMAll Other International — Net Sales
$40.6M+8.0%
The Vita Coco Company, Inc. logo
COCOAll other countries — Net Sales
$32.5M+64.3%
NewMarket logo
NEUAll Other — Net Sales
$4.36M+67.7%
Coca-Cola Consolidated, Inc. logo
COKEAll Other — Net Sales
$92.34M+14.9%
Tempur Sealy International logo
SGIAll other — Net Sales
$410.6M+13.1%
Franklin Electric logo
FELEAll Other — Net Sales
$19M+11.8%

Other financials

Income statement

See full
Revenue$592.1M+1.1%
Gross profit$309.4M+1.1%
Operating income$34.1M+43.9%
Net income-$527.1M-924%
EPS (diluted)-$19.55-954%

Balance sheet

See full
Cash & equivalents$509.0M-2.7%
Total debt$987.3M-28.4%
Total equity$6.9B+2.6%
Total assets$9.8B+2.8%

Cash flow

See full
Operating cash flow$108.1M-16.8%
CapEx$30.0M-12.8%
Free cash flow$78.1M-18.2%

Valuation

See full
Market cap$9.3B+30.0%
Enterprise value$9.78B+19.3%
P/E55.1×+32.7×
P/S3.6×+0.8×

Profitability

See full
Gross margin51.9%-1.6pp
Operating margin8.8%-3.1pp
Net margin6.5%+3.4pp
FCF margin13.8%-0.2pp

Returns & leverage

See full
Return on equity2.5%+1.3pp
Debt / equity0.1×-0.1×
Current ratio3.2×-2.8×

Where this comes from

Reported directly by Bio-Rad Laboratories in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerIncludingAssessedTax.

The source filing: Bio-Rad Laboratories’s 10-K, filed February 13, 2026.

Filed
Feb 12, 2026, 9:50 PM EST
Fiscal year
FY2025
Accession
0000012208-26-000010
Life ScienceClinical DiagnosticsOther Operations
2025$1,021.1$1,562.1
20241,028.11,537.90.5
20231,178.41,489.33.5
2025$468.0$775.3
2024445.7741.30.6
2023514.4725.84.1
2025$553.1$786.8
2024582.4796.6(0.1)

ITEM 8. FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA

FAQ

What is Bio-Rad Laboratories's all other segments — net sales?
Bio-Rad Laboratories (BIO) reported all other segments — net sales of $0 in Q4 2025.
How has Bio-Rad Laboratories's all other segments — net sales changed year-over-year?
Bio-Rad Laboratories's all other segments — net sales decreased by 100.0% year-over-year, from $125K to $0.
What is the long-term trend for Bio-Rad Laboratories's all other segments — net sales?
Over 3 years (2022 to 2025), Bio-Rad Laboratories's all other segments — net sales has grown at a -100.0% compound annual growth rate (CAGR), from $4M to $0.
What does all other segments — net sales mean?
Represents the total revenue generated by business activities categorized within the 'All Other Segments' reporting unit. This segment typically captures non-core, emerging, or legacy operations that do not meet the quantitative thresholds for separate reportable segment disclosure. It reflects the top-line contribution of these miscellaneous business units to the overall corporate revenue.

Ask your AI about Bio-Rad Laboratories's all other segments — net sales.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude